Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07489846 · ClinicalTrials.gov registry record

Xpert® ERP on the GeneXpert® System

A clinical trial, sponsored by Cepheid.

Completed
Registry status
3,200
Enrollment target

NCT07489846: Completed study, sponsored by Cepheid.

NCT07489846 is a clinical trial that has completed, run by Cepheid. The registered enrollment target is 3,200 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07489846 has completed, sponsored by Cepheid.

COMPLETED
Registry status
3,200 participants
Enrollment target

Study Summary

A multi-site observational all-comers study that will be conducted at geographically diverse sites within the United States

Primary Outcome

Evaluating the clinical performance (PPA and NPA) of Xpert ERP relative to comparator(s)

Interventions

  • DIAGNOSTIC_TEST Xpert ERP

Trial Details

FieldValue
Enrollment Target 3,200 participants
Start Date 2025-05-13
Est. Completion 2026-02-02
Cepheid

7 total trials

What the finished NCT07489846 record still lists

NCT07489846 is an observational study that tracks outcomes without assigning an intervention. Its 3,200 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 1 intervention - of which Xpert ERP is the first listed.

NCT07489846 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07489846 about?

NCT07489846 is a clinical study titled "Xpert® ERP on the GeneXpert® System". A multi-site observational all-comers study that will be conducted at geographically diverse sites within the United States

What is the current status of trial NCT07489846?

This trial is currently completed. The enrollment target is 3,200 participants. The study started on 2025-05-13. Estimated completion is 2026-02-02.

What interventions are being tested in trial NCT07489846?

The interventions under investigation include: Xpert ERP (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT07489846?

This trial is sponsored by Cepheid, which has 7 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02043457 · 3,200 participants

    Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance

  • NCT04045665 · 3,200 participants · Phase 3

    Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

  • NCT05381766 · 3,200 participants · NA

    Building Access to Food Through Systems and Solidarity

  • NCT06042543 · 3,200 participants · NA

    Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selection for Cervical Cancer in LMICs

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07489846, the US trial registry maintained by the National Library of Medicine. NCT07489846 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.